Literature DB >> 22420413

Molecular background of D-negative phenotype in the Tunisian population.

H Moussa1, M Tsochandaridis, T Chakroun, S Jridi, B Abdelneji, S Hmida, M Silvy, P Bailly, J Gabert, A Levy-Mozziconacci, Saloua Jemni-Yacoub.   

Abstract

BACKGROUND: Most studies of the molecular basis of Rhesus D-negative phenotype have been conducted in Caucasian and African populations. A comprehensive survey of RHD alleles was lacking in people from North Africa (Tunisians, Moroccans and Algerians) which could be very efficient for managing donors and patients carrying an RHD molecular variant. We analyse the molecular background of D-negative population in Tunisia in the present study.
MATERIALS AND METHODS: Blood samples were collected from native Tunisians. A total of 448 D-negative donors from different regions of Tunisia were analysed by RHD genotyping according to an adopted strategy using real-time PCR, ASP-PCR and sequencing.
RESULTS: Among the 448 D-negative samples, 443 were phenotyped unequivocally as true D-negative including three molecular backgrounds which were RHD gene deletion (n = 437), RHDψ pseudogene (n = 2) and RHD-CE-D hybrid gene (n = 4) with the respective frequencies of 0·9900, 0·0023 and 0·0046. The remaining five samples, in discordance with the serological results, were identified as two weak D type 11, one weak D type 29, one weak D type 4·0 and one DBT-1 partial D.
CONCLUSION: This study showed that the Tunisian population gets closer to Caucasians, given that the RHD gene deletion is the most prevalent cause of D-negative phenotype, but it is slightly different by the presence of the RHDψ pseudogene which was found with a very low frequency compared with that described in the African population. Nevertheless, the relative occurrence of weak D variants among studied serologically D-negative samples make necessary the adaptation of RHD genotyping strategy to the spectrum of prevalent alleles.
© 2012 The Authors. Transfusion Medicine © 2012 British Blood Transfusion Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22420413     DOI: 10.1111/j.1365-3148.2012.01142.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  10 in total

1.  It is worthwhile filling in the remaining blank spots for blood group antigen frequencies.

Authors:  Christof Weinstock
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

3.  Weak D in the Tunisian population.

Authors:  Mouna Ouchari; Houda Romdhane; Taher Chakroun; Saida Abdelkefi; Batoul Houissa; Slama Hmida; Saloua Jemni Yacoub
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

4.  (C)ce(s) haplotype screening in Tunisian blood donors.

Authors:  Hajer Moussa; Néjiba Ghommen; Houda Romdhane; Saadia Abdelkefi; Taher Chakroun; Batoul Houissa; Saloua Yacoub Jemni
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

5.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

6.  Phasing-in RHD genotyping.

Authors:  Willy A Flegel; Susan D Roseff; Ashok Tholpady
Journal:  Arch Pathol Lab Med       Date:  2014-05       Impact factor: 5.534

7.  Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests.

Authors:  Narjes Kacem; Saloua Jemni-Yacoub; Jacques Chiaroni; Pascal Bailly; Monique Silvy
Journal:  Blood Transfus       Date:  2014-06-19       Impact factor: 3.443

8.  Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.

Authors:  Mouna Ouchari; Kshitij Srivastava; Houda Romdhane; Saloua Jemni Yacoub; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-11-29       Impact factor: 3.157

9.  Serologic and molecular characterization of weak D type 29.

Authors:  Mouna Ouchari; Kshitij Srivastava; Andrea Döscher; Roland Conradi; Saloua Jemni Yacoub; Franz Friedrich Wagner; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-07-03       Impact factor: 3.157

Review 10.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.